These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

313 related items for PubMed ID: 17164713

  • 1. Model for end-stage liver disease score-based allocation of donors for liver transplantation: a spanish multicenter experience.
    de la Mata M, Cuende N, Huet J, Bernardos A, Ferrón JA, Santoyo J, Pascasio JM, Rodrigo J, Solórzano G, Martín-Vivaldi R, Alonso M.
    Transplantation; 2006 Dec 15; 82(11):1429-35. PubMed ID: 17164713
    [Abstract] [Full Text] [Related]

  • 2. Predictors of death on the waiting list for liver transplantation characterized by a long waiting time.
    Gheorghe L, Popescu I, Iacob R, Iacob S, Gheorghe C.
    Transpl Int; 2005 May 15; 18(5):572-6. PubMed ID: 15819806
    [Abstract] [Full Text] [Related]

  • 3. Survival on waiting list for liver transplantation before and after introduction of the model for end-stage liver disease score.
    Tenório AL, Macedo FI, Miranda LE, Fernandes JL, da Silva CM, Neto OL, Lacerda CM.
    Transplant Proc; 2010 Mar 15; 42(2):407-11. PubMed ID: 20304152
    [Abstract] [Full Text] [Related]

  • 4. Model for End-Stage Liver Disease (MELD) score system to evaluate patients with viral hepatitis on the waiting list: better than the Child-Turcotte-Pugh (CTP) system?
    Cuomo O, Perrella A, Arenga G.
    Transplant Proc; 2008 Mar 15; 40(6):1906-9. PubMed ID: 18675085
    [Abstract] [Full Text] [Related]

  • 5. Survival benefit after liver transplantation: a single European center experience.
    Ravaioli M, Grazi GL, Dazzi A, Bertuzzo V, Ercolani G, Cescon M, Cucchetti A, Masetti M, Ramacciato G, Pinna AD.
    Transplantation; 2009 Sep 27; 88(6):826-34. PubMed ID: 19920783
    [Abstract] [Full Text] [Related]

  • 6. Assessment of short-term survival after liver transplant by the Model for End-Stage Liver Disease.
    Buenadicha AL, Martín LG, Martín EE, Pajares Ad, Pérez AM, Seral CC, Marugán RB.
    Transplant Proc; 2005 Nov 27; 37(9):3881-3. PubMed ID: 16386571
    [Abstract] [Full Text] [Related]

  • 7. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
    Murillas J, Rimola A, Laguno M, de Lazzari E, Rascón J, Agüero F, Blanco JL, Moitinho E, Moreno A, Miró JM, ESLD-HIV Working Group Investigators.
    Liver Transpl; 2009 Sep 27; 15(9):1133-41. PubMed ID: 19718643
    [Abstract] [Full Text] [Related]

  • 8. Liver transplantation for hepatocellular carcinoma: the MELD impact.
    Sharma P, Balan V, Hernandez JL, Harper AM, Edwards EB, Rodriguez-Luna H, Byrne T, Vargas HE, Mulligan D, Rakela J, Wiesner RH.
    Liver Transpl; 2004 Jan 27; 10(1):36-41. PubMed ID: 14755775
    [Abstract] [Full Text] [Related]

  • 9. Liver transplantation for hepatocellular carcinoma: results of a multicenter study with common priorization criteria.
    Santoyo J, Sanchez B, de la Mata M, Fernández-Aguilar JL, Lopez-Ciller P, Pascasio JM, Suarez MA, Gomez MA, Nogueras F, Muffak K, Cuende N, Alonso M.
    Transplant Proc; 2009 Apr 27; 41(3):1009-11. PubMed ID: 19376412
    [Abstract] [Full Text] [Related]

  • 10. Model for End-Stage Liver Disease (MELD) system to allocate and to share livers: experience of two Italian centers.
    Ravaioli M, Masetti M, Dazzi A, Romano A, Spaggiari M, Grazi GL, Ercolani G, Cescon M, Di Gioia P, De Ruvo N, Montalti R, Ballarin R, Di Benedetto F, Ridolfi L, Alvaro N, Ramacciato G, Morelli C, Gerunda E, Pinna AD.
    Transplant Proc; 2008 Apr 27; 40(6):1814-5. PubMed ID: 18675057
    [Abstract] [Full Text] [Related]

  • 11. Is MELD score sufficient to predict not only death on waiting list, but also post-transplant survival?
    Silberhumer GR, Hetz H, Rasoul-Rockenschaub S, Peck-Radosavljevic M, Soliman T, Steininger R, Muehlbacher F, Berlakovich GA.
    Transpl Int; 2006 Apr 27; 19(4):275-81. PubMed ID: 16573542
    [Abstract] [Full Text] [Related]

  • 12. Model for end-stage liver disease (MELD) and allocation of donor livers.
    Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, Kremers W, Lake J, Howard T, Merion RM, Wolfe RA, Krom R, United Network for Organ Sharing Liver Disease Severity Score Committee.
    Gastroenterology; 2003 Jan 27; 124(1):91-6. PubMed ID: 12512033
    [Abstract] [Full Text] [Related]

  • 13. Algorithm for prioritization of patients on the waiting list for liver transplantation.
    Gambato M, Senzolo M, Canova D, Germani G, Tomat S, Masier A, Russo FP, Perissinotto E, Zanus G, Cillo U, Burra P.
    Transplant Proc; 2007 Jan 27; 39(6):1855-6. PubMed ID: 17692632
    [Abstract] [Full Text] [Related]

  • 14. Is the model of end-stage liver disease (MELD) valid in Israel? A critical analysis of liver transplant waiting list mortality.
    Ben-Haim M, Carmiel M, Katz P, Shabtai E, Oren R, Nakache R.
    Isr Med Assoc J; 2006 Sep 27; 8(9):605-9. PubMed ID: 17058408
    [Abstract] [Full Text] [Related]

  • 15. [The value of MELD in the allocation of priority for liver transplantation candidates].
    Colmenero J, Castro-Narro G, Navasa M.
    Gastroenterol Hepatol; 2010 Apr 27; 33(4):330-6. PubMed ID: 19631411
    [Abstract] [Full Text] [Related]

  • 16. A new priority policy for patients with hepatocellular carcinoma awaiting liver transplantation within the model for end-stage liver disease system.
    Piscaglia F, Camaggi V, Ravaioli M, Grazi GL, Zanello M, Leoni S, Ballardini G, Cavrini G, Pinna AD, Bolondi L.
    Liver Transpl; 2007 Jun 27; 13(6):857-66. PubMed ID: 17539006
    [Abstract] [Full Text] [Related]

  • 17. Model for end-stage liver disease exceptions in the context of the French model for end-stage liver disease score-based liver allocation system.
    Francoz C, Belghiti J, Castaing D, Chazouillères O, Duclos-Vallée JC, Duvoux C, Lerut J, Le Treut YP, Moreau R, Mandot A, Pageaux G, Samuel D, Thabut D, Valla D, Durand F.
    Liver Transpl; 2011 Oct 27; 17(10):1137-51. PubMed ID: 21695771
    [Abstract] [Full Text] [Related]

  • 18. Liver transplantation for hepatocellular carcinoma: impact of the MELD allocation system and predictors of survival.
    Ioannou GN, Perkins JD, Carithers RL.
    Gastroenterology; 2008 May 27; 134(5):1342-51. PubMed ID: 18471511
    [Abstract] [Full Text] [Related]

  • 19. Variability of MELD score during the year before liver transplantation.
    Oton-Nieto E, Barcena-Marugan R, Carrera-Alonso E, Blesa-Radigales C, Garcia-Gonzalez M, Nuño J, Plaza-Palacios G, Garcia-Plaza A.
    Transplant Proc; 2005 Nov 27; 37(9):3887-8. PubMed ID: 16386573
    [Abstract] [Full Text] [Related]

  • 20. Survival before and after model for end-stage liver disease score introduction on the Brazilian liver transplant waiting list.
    Castro RS, Deisanti D, Seva-Pereira T, Almeida JR, Yamanaka A, Boin IF, Soares EC.
    Transplant Proc; 2010 Mar 27; 42(2):412-6. PubMed ID: 20304153
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.